nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora’s box
|
Lazzeroni, Matteo |
|
2017 |
55 |
C |
p. 1-9 9 p. |
artikel |
2 |
Aged patients with metastatic castration resistant prostate cancer: Should we treat with chemotherapy?
|
Climent, Miguel Ángel |
|
2017 |
55 |
C |
p. 173-180 8 p. |
artikel |
3 |
Anti-angiogenic treatment for breast cancer?
|
van Netten, Johannes Pieter |
|
2017 |
55 |
C |
p. 230- 1 p. |
artikel |
4 |
A systematic review: Childhood cancer survivors and gastrointestinal cancer
|
Teepen, Jop C. |
|
2017 |
55 |
C |
p. 210- 1 p. |
artikel |
5 |
A systematic review: Childhood cancer survivors and gastrointestinal cancer
|
Griffin, Isabel |
|
2017 |
55 |
C |
p. 209- 1 p. |
artikel |
6 |
Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature
|
Gravis, Gwenaëlle |
|
2017 |
55 |
C |
p. 211-217 7 p. |
artikel |
7 |
Choosing wisely – Preclinical test models in the era of precision medicine
|
Klinghammer, Konrad |
|
2017 |
55 |
C |
p. 36-45 10 p. |
artikel |
8 |
Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast
|
Martínez-Pérez, Carlos |
|
2017 |
55 |
C |
p. 163-172 10 p. |
artikel |
9 |
Early use of chemotherapy in metastatic prostate cancer
|
Markowski, Mark C. |
|
2017 |
55 |
C |
p. 218-224 7 p. |
artikel |
10 |
Editorial Board
|
|
|
2017 |
55 |
C |
p. IFC- 1 p. |
artikel |
11 |
Epigenetic therapy and chemosensitization in solid malignancy
|
Ronnekleiv-Kelly, Sean M. |
|
2017 |
55 |
C |
p. 200-208 9 p. |
artikel |
12 |
GEIS guidelines for gastrointestinal sarcomas (GIST)
|
Poveda, Andrés |
|
2017 |
55 |
C |
p. 107-119 13 p. |
artikel |
13 |
Health promotion and psychological interventions for adolescent and young adult cancer survivors: A systematic literature review
|
Bradford, Natalie Katrina |
|
2017 |
55 |
C |
p. 57-70 14 p. |
artikel |
14 |
Immunologic approaches for the treatment of multiple myeloma
|
Rasche, Leo |
|
2017 |
55 |
C |
p. 190-199 10 p. |
artikel |
15 |
Increased life expectancy as a result of non-hormonal targeted therapies for HER2 or hormone receptor positive metastatic breast cancer: A systematic review and meta-analysis
|
Koleva-Kolarova, Rositsa G. |
|
2017 |
55 |
C |
p. 16-25 10 p. |
artikel |
16 |
Local co-administration of gene-silencing RNA and drugs in cancer therapy: State-of-the art and therapeutic potential
|
Larsson, Mikael |
|
2017 |
55 |
C |
p. 128-135 8 p. |
artikel |
17 |
Metformin and improved treatment outcomes in radiation therapy – A review
|
Samsuri, Nur Atiqah Binte |
|
2017 |
55 |
C |
p. 150-162 13 p. |
artikel |
18 |
Metronomic and metronomic-like therapies in neuroendocrine tumors – Rationale and clinical perspectives
|
Lambrescu, Ioana |
|
2017 |
55 |
C |
p. 46-56 11 p. |
artikel |
19 |
Mutation matters in precision medicine: A future to believe in
|
Dey, Nandini |
|
2017 |
55 |
C |
p. 136-149 14 p. |
artikel |
20 |
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition
|
Facchinetti, Francesco |
|
2017 |
55 |
C |
p. 83-95 13 p. |
artikel |
21 |
Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause
|
Nourmoussavi, Melica |
|
2017 |
55 |
C |
p. 26-35 10 p. |
artikel |
22 |
Reply to response to Wheatley et al., “Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation” Cancer Treatment Reviews April 2016;45:76
|
Wheatley, Keith |
|
2017 |
55 |
C |
p. 225-229 5 p. |
artikel |
23 |
Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis
|
Costa, R. |
|
2017 |
55 |
C |
p. 10-15 6 p. |
artikel |
24 |
The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy
|
Mok, Tony S.K. |
|
2017 |
55 |
C |
p. 181-189 9 p. |
artikel |
25 |
The impact of neoadjuvant therapy on the histopathological features of pancreatic ductal adenocarcinoma – A systematic review and meta-analysis
|
Schorn, Stephan |
|
2017 |
55 |
C |
p. 96-106 11 p. |
artikel |
26 |
The mortality reducing effect of aspirin in colorectal cancer patients: Interpreting the evidence
|
Frouws, Martine A. |
|
2017 |
55 |
C |
p. 120-127 8 p. |
artikel |
27 |
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide
|
Del Re, Marzia |
|
2017 |
55 |
C |
p. 71-82 12 p. |
artikel |